Expression of and response to interleukin 6 (IL6) in human mammary tumors

Cancer Research

Volumn 56, Issue 13, 1996, Pages 3118-3122

  Basolo, Fulvio ^a   Fiore, Lisa ^a   Fontanini, Gabrielia ^a   Conaldi, Pier Giulio ^b   Calvo, Simonetta ^a   Falcone, Valeria ^b   Toniolo, Antonio ^b  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BREAST CANCER; BREAST CARCINOMA; BREAST EPITHELIUM; CANCER GROWTH; CONTROLLED STUDY; DNA SYNTHESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; MEDULLARY CARCINOMA; PRIORITY JOURNAL;

BREAST; BREAST NEOPLASMS; CELLS, CULTURED; CYTOKINES; EPITHELIUM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-6; REFERENCE VALUES; TUMOR CELLS, CULTURED;

EID: 0029938778     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Basolo, F., Conaldi, P. G., Fiore, L., Calvo, S , and Toniolo, A. Normal breast epithelial cells produce interleukin 6 and 8 together with tumor-necrosis factor defective IL6 expression in mammary carcinoma. Int. J. Cancer, 55. 1-5, 1993.
2. Soule, H., Moloney, T., Wolman, S R., Peterson, W D., Brenz, R , Mac Grath, C. M., Russo, J., Pauley, R. J , Jones, R. F., and Brooks, S. C. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line MCF-10A. Cancer Res., 50: 6075-6086, 1990.
3. Basolo, F., Calvo, S., Fiore, L., Conaldi, P. G., Falcone, V., and Toniolo, A. Growth-stimulating activity of interleukin 6 (IL6) on human mammary epithelial cells transfected with the int-2 gene. Cancer Res , 53: 2957-2960, 1993.
4. Basolo, F., Fiore L., Calvo, S., Falcone, V , Conaldi, P. G., Fontanini, G., Caligo, A. M , Merlo, G., Gluzman, Y., and Toniolo, A Defective IL6 expression and responsiveness in human mammary cells transformed by an adeno-5/SV40 hybrid virus. Br. J. Cancer, in press, 1996.
5. Hirano, T Interleukin-6. In: A Thomson (ed.). The Cytokine Handbook, pp. 145-168. London: Academic Press, 1994
6. Michiel, D. F., and Oppenheim, J J. Cytokines as positive and negative regulators of tumor promotion and progression Semin. Cancer Biol., 3: 3-15, 1992
7. Castelli, C , Sensi, M., Lupetti, R , Mortarini, R., Panceri, P., Anichini, A., and Parmiani, G. Expression of interieukin 1α, interleukin 6, and tumor necrosis factor α genes in human melanoma clones is associated with that of mutated N-ras oncogene. Cancer Res., 54: 4785-4790, 1994.
8. Spangelo, B L , MacLeod, R M , and Isakson, P. C. Production of Interleukin-6 by anterior pituitary cells in vitro. Endocrinology, 126: 582-586, 1990.
9. Ray, A., and Prefontaine, K. E. Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor Proc. Natl. Acad. Sci. USA, 91: 752-756, 1994.
10. Silvani, A., Ferrari, G., Paonessa, G., Toniatti, C., Parmiani, G., and Colombo, M. P. Down-regulation of interleukin 6 receptor a chain in interleukin 6 transduced melanoma cells causes selective resistance to interleukin 6 but not 10 oncostatin M. Cancer Res., 55: 2200-2205, 1995.
11. Candour-Edwards, R., Kapadia, S B , Janecka, I. P., Martinez, A. J., and Barnes, L Biological markers of invasive pituitary adenomas involving the sphenoid sinus Mod. Pathol., 8: 160-164, 1995
12. Basolo, F., Fiore, L., Ciardiello, F., Calvo, S , Fontanini, G., Conaldi, P. G., and Toniolo, A. Response of normal and oncogene-transformed human mammary epithelial cells to transforming growth factor β (TGF-β1), lack of growth-inhibitory effect on cells expressing the simian virus 40 large-T antigen Int J. Cancer, 56: 736-742, 1994.
13. Rosen, P P., and Oberman, H. A. Tumors of the mammary gland In. J Rosai (ed.), Atlas of Tumor Pathology, pp. 7-10. Washington DC. Armed Forces Institute of Pathology, 1993.
14. Porter, J. K., and Lippman, M E. Overview of the biologic markers of breast cancer. Hematol. Oncol. Clin. North Am., 8: 73-100, 1994
15. Massagué, J., Cheifetz, S., Latho, M , Ralph, D A., Weis, F. M B , and Zentella, A Transforming growth factor-β. In. A. J. Levine (ed ), Tumor Suppressor Genes, the Cell Cycle and Cancer, pp. 81-103. Cold Spring Harbor, NY Cold Spring Harbor Laboratory, 1992.
16. Arteaga, C. L , Hurd, S. D., Winnier, A. R., Johnson, M. D., Fendly, B. M., and Forbes, J. T. Anti-transforming growth factor (TGF)-β antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-β interactions in human breast cancer progression. J Clin. Invest., 92: 2569-2576, 1993
17. Danforth, D. N., and Sagias, M. K. Interleukin-1 α and interleukin-6 act additively to inhibit growth of MCF-7 breast cancer cells in vitro. Cancer Res., 53: 1538-1545, 1993
18. Speirs, V., Birch, M A., Boyle-Walsh, E., Green, A. R., Gallagher, J. A., and White, M. C. Interleukin-3: a putative protective effector against breast cancer which is secreted by male but not female breast fibroblasts. Int. J. Cancer, 61: 416-419, 1995.
19. Silberstein, G B., Flanders, K. C., Roberts, A. B., and Daniel, C W. Regulation of mammary morphogenesis: evidence for extracellular matrix-mediated inhibition of ductal budding by transforming growth factor-β 1. Dev Biol., 152: 354-362, 1992.
20. Stampfer, M. R , Yaswen, P., Alhadeff, M., and Hosoda, J. TGF-β induction of extracellular matrix associated proteins in normal and transformed human mammary epithelial cells in culture is independent of growth effects. J Cell. Physiol., 155: 210-221, 1993.
21. Garver, R. I., Radford, D M., Donis-Keller, H., Wick, M. R , and Milner, P. G Midkine and pleiotrophin expression in normal and malignant breast tissue Cancer (Phila.), 74: 1584-1590, 1994.
22. Allione, A., Consalvo, M., Nanni, P., Lollini, P. L., Cavallo, F. Giovarelli, M., Forni, M., Gulino, A , Colombo, M. P., Dellabona, P , Hock, H., Blankestein, T., Rosenthal, F. M., Gansbacher, B., Bosco, M. C., Musso, T , Gusella, L., and Forni, G. Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumor necrosis factor α, granulocyte-macrophage colony-stimulating factor, and γ-interferon gene or admixed with conventional adjuvants. Cancer Res., 54: 6022-6026, 1994.
23. Schor, A. M., Rushton, G., Ferguson, J. E., Howell, A., Redford, J., and Schor, L. S. Phenotypic heterogeneity in breast fibroblasts: functional anomaly in fibroblasts from histologically normal tissue adjacent to carcinoma. Int. J. Cancer, 59: 25-32, 1994.
24. Spanakis, E., and Brouty-Boye, D. Quantitative variation of proto-oncogene and cytokine gene expression in isolated breast fibroblasts. Int. J. Cancer, 61: 698-705, 1995.
25. Gomm, J J , Smith, J., Ryall, G. K., Baillie, R., Turnbull, L., and Coombes, R. C Localization of basic fibroblast growth factor and transforming growth factor b1 in the human mammary gland. Cancer Res., 51: 4685-4692, 1991.
26. Shi, Y. E., Liu, Y. E., Lippman, M. E , and Dickson, R. B. Progestins and antiprogestins in mammary tumour growth and metastasis. Hum. Reprod. (Oxf), 9: 162-173, 1994.
27. Pierce, D. F., Johnson, M. D., Matsui, Y., Robinson, S. D., Gold, L. I., Purchio, A F., Daniel, C. W., Hogan, B. L., and Moses, H. L. Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF-β 1. Genes Dev., 7. 2308-2317, 1993.
28. Gandour-Edwards, R., Kapadia, S. B., Gumerlock, P. H., and Barnes, A. L. Immunolocalization of interleukin-6 in salivary gland tumors. Hum. Pathol., 26: 501-503, 1995.
29. Lu, C., and Kerbel, R. S. Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression. J. Cell. Biol., 120: 1281-1288, 1993.
30. Takizawa, H , Ohtoshi, T , Ohta, K., Yamashita, N., Hirohata, S., Hirai, K., Hiramatsu, K , and Ito, K. Growth inhibition of human lung cancer cell lines by interleukin 6 in vitro a possible role in tumor growth via an autocrine mechanism Cancer Res., 53: 4175-4181, 1993.
31. Chen, I , Mory, Y., Zilberstein, A., and Revel, M. Growth inhibition of human breast carcinoma and leukemia/lymphoma cell lines by recombinant interferon-β. Proc. Nati. Acad. Sci. USA, 85: 8037-8041, 1988.
32. Freeman, G. J., Freedman, A. S., Rabinowe, S. N., Segil, J. M , Horowitz, J., Rosen, K., Whitman, J F., and Nadler, L. M. Interleukin 6 gene expression in normal and neoplastic B cells. J Clin. Invest., 83: 1512-1518, 1989
33. Ohtake, K., Yano, T., Kameda, K , and Ogawa, T. Detection of interleukin 6 (IL6) in human bone marrow myeloma cells by light and electron microscopy. Am. J. Hematol., 35: 84-87, 1990.
34. 1 associates with disease progression in human breast cancer. Cancer Res., 52: 6949-6952, 1992.
35. Walker, R. A., and Dearing, S J Transforming growth factor β1 in ductal carcinoma in situ and invasive carcinomas of the breast Eur J Cancer, 28: 641-644, 1992.
36. Barrett-Lee, P., Travers, M., Luqmani, Y., and Coombes, R. C. Transcripts for transforming srowth factors in human breast cancer: clinical correlates. Br J. Cancer. 61: 612-617, 1990.
37. Revel, M. Growth regulatory functions of IL6 and antitumour effects. Res. Immunol., 143: 769-773, 1992.